New GV Investment Is the Latest in Hot Immunotherapy Space – Bloomberg
|
New GV Investment Is the Latest in Hot Immunotherapy Space
Bloomberg The growing promise of immunotherapy is attracting attention from scientists and startups. Companies trying to cure cancer raised roughly $4 billion from venture investors last year, with an increasing number focused on reprogramming a patient's own … |
